To delineate the binding site of RORα on the Prl promoter, an electrophoretic mobility shift assay (EMSA) was conducted using human nonfunctional pituitary adenoma, which was diagnosed based on normal hormone levels and negative immunohistochemical staining. This evidence concerns the gene RORA and pituitary gland adenoma.